Overview

Intravenous Dexamethasone to Increase the Analgesic Duration of Interscalene Block

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Interscalene brachial plexus block provides excellent but time limited analgesia. Intravenous dexamethasone increases the analgesic duration of a single-shot interscalene block with ropivacaine for shoulder arthroscopic surgery. We want to evaluate the effect of two different doses (dexamethasone 10 mg i.v. vs 4 mg i.v. vs placebo) on the analgesic duration of a single-shot inter scalene block. Our study hypothesis is that dexamethasone 4 mg i.v. is equivalent to dexamethasone10 mg i.v. in prolonging the analgesic duration of a single-shot interscalene block with ropivacaine.
Phase:
N/A
Details
Lead Sponsor:
Maisonneuve-Rosemont Hospital
Treatments:
Analgesics
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate